0.761
Precedente Chiudi:
$0.741
Aprire:
$0.73
Volume 24 ore:
133.05K
Relative Volume:
0.45
Capitalizzazione di mercato:
$96.00M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.3589
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
+3.55%
1M Prestazione:
+5.99%
6M Prestazione:
-60.36%
1 anno Prestazione:
-72.53%
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Confronta NAUT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NAUT
Nautilus Biotechnology Inc
|
0.761 | 92.72M | 0 | -70.78M | -61.27M | -0.56 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-05 | Downgrade | Goldman | Neutral → Sell |
2024-06-27 | Iniziato | Guggenheim | Buy |
2024-06-03 | Ripresa | Jefferies | Hold |
2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
2021-11-02 | Iniziato | Cowen | Outperform |
2021-08-04 | Iniziato | Goldman | Neutral |
2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology (NAUT) to Release Earnings on Thursday - Defense World
Is Nautilus Biotechnology Inc. a good long term investmentTremendous gains - Autocar Professional
What analysts say about Nautilus Biotechnology Inc. stockMarket-beating performance - jammulinksnews.com
What makes Nautilus Biotechnology Inc. stock price move sharplyProfessional Stock Screener - Newser
What drives Nautilus Biotechnology Inc. stock priceFree Capital Growth Strategies - jammulinksnews.com
How Nautilus Biotechnology Inc. stock performs during market volatilityWeekly Big Movers - Newser
Nautilus Biotechnology Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 - 富途牛牛
What analysts say about Digital Ally Inc. stockSuperior risk-adjusted returns - Jammu Links News
Best Stocks for Conservative Investors in India Expert Long Term StocksExplosive capital appreciation - Jammu Links News
Macro Trends and Their Impact on Visaka Industries Limited (509055)Tremendous wealth creation - Jammu Links News
What makes Stagwell Inc. stock price move sharplyHigh Reward Swing Trades - Newser
Why HLXCP stock attracts strong analyst attentionOptimized Return Investment Picks - Newser
Why TSHA stock attracts strong analyst attentionWeekly Big Movers - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser
Why Veris Residential Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser
Nautilus Biotechnology's Q2 2025: Can Proteomics Innovation Drive the Next Phase of Growth? - AInvest
Nautilus Biotechnology, Inc. to Report Second Quarter 2025 Financial Results and Host Webcast Conference Call - Nasdaq
What makes L.B. Foster Company stock price move sharplyDaily Swing Candidates - Newser
How ARAY stock performs during market volatilityFree Access to Community - Newser
Why GGAL stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser
hpepe(hero pepe) price forecastProven Win Setups - Newser
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 7.5% – Should You Sell? - Defense World
The Next Generation of Proteome Analysis - the-scientist.com
Insiders of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) have had a great week after last week's US$12m gain and they haven't stopped buying - Yahoo Finance
EDGE(dadi) Price TodaySecure Your Capital Strategy - newser.com
Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC - Defense World
Home Product Center Public (OTCMKTS:HPCRF) Trading Up 20.5% – Should You Buy? - Defense World
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Bought by Jane Street Group LLC - Defense World
Citadel Advisors LLC Raises Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer - Business Wire
Northern Trust Corp Sells 32,695 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):